A major challenge for the discovery of protein kinase inhibitors is to identify potent, selective, and novel pharmacophores. In this issue, Fedorov et al. (2011) describes KH-CB19, an ATP-competitive inhibitor of cdc2-like kinase that interacts with the ATP hinge region through a halogen-bonding motif.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.chembiol.2011.01.003 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!